RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 76 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $541,000 | +66.5% | 60,381 | -0.4% | 0.00% | – |
| Q2 2016 | $325,000 | +33.7% | 60,596 | +10.1% | 0.00% | – |
| Q1 2016 | $243,000 | -12.6% | 55,045 | +3.2% | 0.00% | – |
| Q4 2015 | $278,000 | -12.9% | 53,331 | +1.4% | 0.00% | – |
| Q3 2015 | $319,000 | -60.6% | 52,598 | +2.7% | 0.00% | -100.0% |
| Q2 2015 | $809,000 | +74.7% | 51,226 | +20.3% | 0.00% | 0.0% |
| Q1 2015 | $463,000 | +7.4% | 42,590 | +4.0% | 0.00% | 0.0% |
| Q4 2014 | $431,000 | +8.8% | 40,935 | -0.8% | 0.00% | 0.0% |
| Q3 2014 | $396,000 | -15.0% | 41,259 | +2.3% | 0.00% | 0.0% |
| Q2 2014 | $466,000 | +2.4% | 40,348 | -11.4% | 0.00% | 0.0% |
| Q1 2014 | $455,000 | -23.7% | 45,514 | -0.6% | 0.00% | 0.0% |
| Q4 2013 | $596,000 | -8.3% | 45,798 | +5.2% | 0.00% | 0.0% |
| Q3 2013 | $650,000 | +51.9% | 43,516 | -5.0% | 0.00% | 0.0% |
| Q2 2013 | $428,000 | – | 45,828 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |